U.S. flag

An official website of the United States government

NM_000348.4(SRD5A2):c.433C>T (p.Arg145Trp) AND 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003501403.2

Allele description [Variation Report for NM_000348.4(SRD5A2):c.433C>T (p.Arg145Trp)]

NM_000348.4(SRD5A2):c.433C>T (p.Arg145Trp)

Gene:
SRD5A2:steroid 5 alpha-reductase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p23.1
Genomic location:
Preferred name:
NM_000348.4(SRD5A2):c.433C>T (p.Arg145Trp)
HGVS:
  • NC_000002.12:g.31533615G>A
  • NG_008365.1:g.52357C>T
  • NG_008365.2:g.134394C>T
  • NM_000348.4:c.433C>TMANE SELECT
  • NP_000339.2:p.Arg145Trp
  • NC_000002.11:g.31758685G>A
Protein change:
R145W
Molecular consequence:
  • NM_000348.4:c.433C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency (PPSH)
Synonyms:
Pseudovaginal perineoscrotal hypospadias; Male pseudohermaphroditism due to 5-alpha-reductase deficiency; Familial incomplete male pseudohermaphroditism, type 2; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009923; MedGen: C0268297; Orphanet: 753; OMIM: 264600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004271508Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Dec 13, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Steroid 5 alpha-reductase 2 deficiency.

Wilson JD, Griffin JE, Russell DW.

Endocr Rev. 1993 Oct;14(5):577-93. Review.

PubMed [citation]
PMID:
8262007

SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects.

Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, Gennari M, Radetti G, Cacciari E, Cicognani A.

Clin Endocrinol (Oxf). 2005 Oct;63(4):375-80.

PubMed [citation]
PMID:
16181229
See all PubMed Citations (8)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004271508.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 145 of the SRD5A2 protein (p.Arg145Trp). This variant is present in population databases (rs759561106, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of steroid-5 alpha-reductase deficiency (PMID: 8262007, 16181229, 32713132, 35700942). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SRD5A2 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects SRD5A2 function (PMID: 8110760, 32380235). This variant disrupts the p.Arg145 amino acid residue in SRD5A2. Other variant(s) that disrupt this residue have been observed in individuals with SRD5A2-related conditions (PMID: 25899528), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024